Filgrastim versus TBO‐filgrastim to reduce the duration of neutropenia after autologous hematopoietic stem cell transplantation: TBO, or not TBO, that is the question

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|12|1128-1132

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.12, 2015-12, pp. : 1128-1132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison between biosimilar filgrastim vs other granulocyte‐colony stimulating factor formulations (originator filgrastim, peg‐filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 2, 2015-04 ,pp. : 293-296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2709-2713

John Wiley & Sons Inc

Access to resources Recommend Favorite

Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 93-97

Karger

Access to resources Recommend Favorite

Autoimmune Thrombocytopenia and Neutropenia after Autologous Peripheral Blood Stem Cell Transplantation

By  

Acta Haematologica, Vol. 107, Iss. 4, 2002-05 ,pp. : 237-238

Karger

Access to resources Recommend Favorite

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 239-247

Karger

Access to resources Recommend Favorite